UFM1
Ubiquitin-fold modifier 1
Also known as: bA131P10.1, C13orf20, UFM1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P61960
- Gene
- UFM1
- Ensembl
- ENSG00000120686
- Chromosome
- 13
- Canonical length
- 85 aa
- Protein class
- Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins
OverviewNCBI Gene
UFM1 is a ubiquitin-like protein that is conjugated to target proteins by E1-like activating enzyme UBA5 (UBE1DC1; MIM 610552) and E2-like conjugating enzyme UFC1 (MIM 610554) in a manner analogous to ubiquitylation (see UBE2M; MIM 603173) (Komatsu et al., 2004 [PubMed 15071506]).[supplied by OMIM, Dec 2008]
Canonical amino-acid sequenceUniProt
85 residues, UniProt reviewed canonical sequence.
>P61960|UFM1
1 MSKVSFKITL TSDPRLPYKV LSVPESTPFT AVLKFAAEEF KVPAATSAII TNDGIGINPA
61 QTAGNVFLKH GSELRIIPRD RVGSCLocalizationUniProt · AlphaFold · HPA
Whether an antibody against UFM1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 94 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 94 nTPM
- epididymis: 61 nTPM
- pancreas: 61 nTPM
- salivary gland: 55 nTPM
- endometrium: 55 nTPM
- spinal cord: 50 nTPM
Single-cell type
- esophageal apical cells: 309 nCPM
- plasma cells: 305 nCPM
- gastric progenitor cells: 250 nCPM
- pancreatic acinar cells: 239 nCPM
- parietal cells: 225 nCPM
- gastric chief cells: 223 nCPM
Immune cell
- basophil: 72 nTPM
- plasmacytoid DC: 45 nTPM
- intermediate monocyte: 42 nTPM
- eosinophil: 41 nTPM
- non-classical monocyte: 40 nTPM
- memory B-cell: 40 nTPM
Brain region
- white matter: 60 nTPM
- hypothalamus: 58 nTPM
- choroid plexus: 55 nTPM
- spinal cord: 55 nTPM
- medulla oblongata: 52 nTPM
- pons: 51 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about UFM1.
Disease | AllUniProt
Conditions UFM1 is implicated in, by any mechanism.
- Leukodystrophy, hypomyelinating, 14 (HLD14) MIM:617899
Disease | GeneticClinVar
4 pathogenic / likely-pathogenic of 60 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Leukodystrophy, hypomyelinating, 14
- Congenital long QT syndrome
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.03
- gnomAD pLI
- 0.16
- gnomAD missense Z
- 0.62
- DepMap mean gene effect
- -0.5
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- brain development
- negative regulation of apoptotic process
- negative regulation of protein import into nucleus
- protein K69-linked ufmylation
- protein ufmylation
- regulation of intracellular estrogen receptor signaling pathway
- response to endoplasmic reticulum stress
- reticulophagy
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Ubiquitin-like domain superfamily
- Ubiquitin-fold modifier 1
- Ubiquitin fold modifier 1 protein
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of UFM1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads UFM1 as an antibody target. Whether an autoantibody or antibody against UFM1 could matter depends on whether native UFM1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
UFM1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label UFM1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...